Extension Study for 43USSA1705

NCT04225273 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
38
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Galderma R&D